A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Paclitaxel|DRUG: Reolysin
Sponsor: Canadian Cancer Trials Group
Collaborators: Oncolytics Biotech